Digital Sponsored Webinar wrap-up: How pharma can leverage AI-driven synthetic... Synthetic personas turn static, traditional personas into interactive, evidence-backed simulations.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
Digital Sponsored Expert Directed Applied Intelligence: Redefining AI in Life ... In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Sales & Marketing Sponsored The strategic imperative of Integrated Evidence Generation P... Integrated Evidence Generation Planning (IEGP) is recognised as a strategic necessity for biopharmaceutical organisations.
R&D Sponsored A New Framework to Engineer Breakthrough Value for Medicines A new white paper from Lumanity – ‘A New Framework to Engineer Breakthrough Value for Medicines: Value Inflection Points Across the Development Path’.
Digital Cracking the code: Unlocking key opinion leaders in the digi... With new guidance, treatment pathways, and medical advances emerging on a regular basis, the pursuit of knowledge and innovation is a never-ending process for healthcare providers.
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.